Characterization of the core and surface of human plasma lipoproteins. A study based on the use of five fluorophores

1991 ◽  
Vol 60 (1) ◽  
pp. 1-14 ◽  
Author(s):  
Vered Ben-Yashar ◽  
Yechezkel Barenholz
2018 ◽  
Vol 411 (3) ◽  
pp. 777-786 ◽  
Author(s):  
Carmen R. M. Bria ◽  
Farsad Afshinnia ◽  
Patrick W. Skelly ◽  
Thekkelnaycke M. Rajendiran ◽  
Pradeep Kayampilly ◽  
...  

1976 ◽  
Vol 434 (2) ◽  
pp. 419-427 ◽  
Author(s):  
Josef R. Patsch ◽  
Wolfgang Patsch ◽  
Sigurd Sailer ◽  
Herbert Braun-Steiner

PROTEOMICS ◽  
2005 ◽  
Vol 5 (10) ◽  
pp. 2619-2630 ◽  
Author(s):  
Manfred Heller ◽  
Daniel Stalder ◽  
Evelyn Schlappritzi ◽  
Gertraud Hayn ◽  
Urs Matter ◽  
...  

1992 ◽  
Vol 33 (12) ◽  
pp. 1785-1796
Author(s):  
F Blanco-Vaca ◽  
DP Via ◽  
CY Yang ◽  
JB Massey ◽  
HJ Pownall

Steroids ◽  
1989 ◽  
Vol 54 (1) ◽  
pp. 37-53 ◽  
Author(s):  
Dennis E. Leszczynski ◽  
Robert M. Schafer

1976 ◽  
Vol 35 (01) ◽  
pp. 178-185 ◽  
Author(s):  
Helena Sandberg ◽  
Lars-Olov Andersson

SummaryHuman plasma lipoprotein fractions were prepared by flotation in the ultracentrifuge. Addition of these fractions to platelet-rich, platelet-poor and platelet-free plasma affected the partial thromboplastin and Stypven clotting times to various degrees. Addition of high density lipoprotein (HDL) to platelet-poor and platelet-free plasma shortened both the partial thromboplastin and the Stypven time, whereas addition of low density lipoprotein and very low density lipoprotein (LDL + VLDL) fractions only shortened the Stypven time. The additions had little or no effect in platelet-rich plasma.Experiments involving the addition of anti-HDL antibodies to plasmas with different platelet contents and measuring of clotting times produced results that were in good agreement with those noted when lipoprotein was added. The relation between structure and the clot-promoting activity of various phospholipid components is discussed.


Sign in / Sign up

Export Citation Format

Share Document